Trelys

San Francisco, United States Founded: 2012 • Age: 14 yrs
Produces bio animal feed ingredients using methanogen bioconversion technology.
Annual revenue - Latest available
Total funding $2.6M 2 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Trelys

Trelys is a company based in San Francisco (United States) founded in 2012. It operates as a B2B. Trelys has raised $2.58 million across 2 funding rounds. Trelys operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.

  • Headquarter San Francisco, United States
  • Sectors
    Agriculture
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Agriculture → Livestock & Animal Nutrition Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $2.58 M (USD)

    in 2 rounds

  • Latest Funding Round
    $80 K (USD), Seed

    Apr 12, 2017

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Trelys

Trelys has successfully raised a total of $2.58M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $80 thousand completed in April 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Trelys

Investments
Premium access

Investment portfolio details for Trelys

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Trelys

Premium access

Detailed financials for Trelys

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Trelys Comparisons

Trelys Primary company
Description
Produces bio animal feed ingredients using methanogen biocon...
Location
San Francisco, United States
Founded Year
2012
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Trelys

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Trelys

Trelys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Antibody-siRNA complexes are developed for cancer treatment.
Locked Locked Locked
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
Locked Locked Locked
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
Locked Locked Locked
Developing novel drugs based on a proteome-wide ligand and target discovery platform
Locked Locked Locked
RNA-editing technologies are provided for precision medicine applications.
Locked Locked Locked
Dental implants and regenerative dentistry products are developed.
Premium access

Detailed competitors of Trelys

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Trelys

Premium access

Complete news archive for Trelys

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Trelys

Trelys was founded in 2012 and raised its 1st funding round 1 year after it was founded.

Trelys is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Trelys is a funded company, having raised a total of $2.58M across 2 funding rounds to date.

Trelys produces bio animal feed ingredients using methanogen bioconversion technology, focusing on food and agriculture, engaging in agricultural activities, animal feed production, and bio ingredients. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Trelys's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available